ClinicalTrials.gg

Neurodegenerative Diseases clinical trials

The registry lists 436 studies for Neurodegenerative Diseases across more than 10 countries. 143 are recruiting or about to start. 86 of them are mainly about Neurodegenerative Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 51 narrower conditions too, such as Parkinson Disease: 12,899 studies, 3,184 open.

Get an email when these change. Save the Neurodegenerative Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
182
Recruiting
101
Status unknown
34
Active, not recruiting
30
Terminated
29
Not yet recruiting
25

Phase

Phase 2
83
Phase 1
54
Phase 3
32
Early Phase 1
5
Phase 4
3

Where

United States
176
Italy
67
France
67
United Kingdom
50
Germany
49
Spain
43

What is being tested here

Drugs under test in Neurodegenerative Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here Dopamine agonists 7 · Cholinesterase inhibitors 4

Coming up

42studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 101 Neurodegenerative Diseases studies recruiting now, 52 (51%) set no upper age limit and 11 (11%) stop at 75 or younger. 20 (20%) take children under 18. 1 (1%) are for women only and 0 (0%) for men only; 49 (49%) take healthy volunteers.

Recruiting studies that take each age, of 101
AgeWomenMen
1019 (19%)19 (19%)
1859 (58%)58 (57%)
3069 (68%)68 (67%)
4077 (76%)76 (75%)
5088 (87%)87 (86%)
6597 (96%)96 (95%)
7593 (92%)92 (91%)
8573 (72%)72 (71%)

Across all 436 studies, recruiting or not: 15% stop at 75 or younger and 5% at 65; 15% take children; 1% are for women only and <1% for men only; 32% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Neurodegenerative Diseases studies take

Of 35 phase 2 interventional studies under Neurodegenerative Diseases, half reached primary completion within 30 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 122 mo11–41 · 29 studies——
Phase 230 mo22–47 · 35 studies——
Phase 353 mo34–56 · 16 studies——
Interventional, no phase35 mo11–67 · 82 studies—35 mo10–57 · 75 studies
Observational94 mo39–216 · 82 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 436. Browse all 436 → or search them.